Products

Powering Precision Oncology with AI and Single Cell Innovation

We develop advanced tools at the intersection of molecular science, bioinformatics, and artificial intelligence. Our suite of products is designed to provide clinicians, researchers, and pharma/biopharma partners with high-resolution, real-time insights to improve cancer diagnosis, monitoring, and treatment. Each product is purpose-built to address the most pressing challenges in precision oncology — from capturing rare circulating tumor cells to unlocking singlecell multi-omics data.

Explore our portfolio below and discover how our technologies are reshaping the future of cancer care.

Explore Our AI-Powered Oncology Solutions

OncoIncytes®

Investigating Live Circulating Cancer Cells

OncoIncytes is our proprietary next generation liquid biopsy platform focused on isolating and analyzing live circulating tumor cells (CTCs) in real time. Unlike traditional liquid biopsies that focus on circulating tumor DNA (ctDNA), OncoIncytes captures intact, viable CTCs—providing critical molecular information.

Detect cancer earlier

Monitor disease progression

Guide personalized therapy decisions

Understand tumor heterogeneity at the cellular level

By delivering a deeper, more dynamic profile of each patient’s cancer, OncoIncytes empowers oncologists with actionable insights when it matters most.

1Cell SOLO®

Automation to Capture True Single Cells

1Cell SOLO is an AI-driven single cell isolation system designed to capture and analyze individual tumor cells with unparalleled precision. Built to support high-resolution research and clinical applications.

Precise capture of true single cells

High-throughput processing with minimal contamination

Multi-omics analysis at the cellular level

Acceleration of oncology research, drug development, and biomarker discovery

With the SOLO, researchers and clinicians can explore cancer at its most fundamental level—advancing personalized care and therapeutic innovation.

1Cell iCORE®

AI platform to accelerate translational research workflows and optimize precision medicine trials

The 1Cell iCORE Platform is a groundbreaking convergence of advanced artificial intelligence and unified informatics infrastructure, purpose-built to redefine translational research and precision medicine trials. By deploying proprietary machine learning architectures and predictive analytics.

Accelerate biomarker discovery

Decipher multi-modal biological datasets such as multi-omics, imaging and clinical data

Streamline design of bio-marker rich clinical studies

Optimize trial protocols

With the iCORE, oncologists and researchers can explore how it powers the future of biomarker-driven therapeutics

Technology at Work: AI Meets Multi-omics

Redefining the Future of Cancer Care OneCell Ai’s technology is driving a new standard in oncology, drug development, and precision medicine. By unlocking cell-level intelligence with AI, we empower healthcare professionals with the tools needed to make smarter, faster, and more personalized treatment decisions.

Next-Generation Sequencing (NGS)

High-throughput genomic analysis.

Machine Learning & Bioinformatics

AI models trained on diverse oncology datasets.

Data-Driven Biomarker Discovery

Multiomics insights for precision treatment planning.

Collaboration